語系:
繁體中文
English
日文
簡体中文
說明(常見問題)
登入
回首頁
切換:
標籤
|
MARC模式
|
ISBD
The new political economy of pharmac...
~
L�ofgren, Hans, (1953-)
The new political economy of pharmaceuticals[electronic resource] :production, innnovation and trips in the global south /
紀錄類型:
書目-語言資料,印刷品 : Monograph/item
杜威分類號:
338.4/76151
書名/作者:
The new political economy of pharmaceuticals : production, innnovation and trips in the global south // edited by Hans L�ofgren, associate professor, School of Humanities and Social Sciences, Deakin University, Australia and Owain David Williams, research fellow, Centre for Health and International Relations, Aberystwyth University, UK.
其他作者:
L�ofgren, Hans,
面頁冊數:
1 online resource (pages cm.)
標題:
BUSINESS & ECONOMICS / Industries / General
標題:
Pharmaceutical policy - International cooperation.
標題:
Pharmaceutical industry - Economic aspects
標題:
Drugs - Patents.
標題:
Patents (International law)
標題:
POLITICAL SCIENCE - International Relations
標題:
POLITICAL SCIENCE - Public Policy
標題:
POLITICAL SCIENCE - Political Freedom & Security
標題:
POLITICAL SCIENCE - Government
標題:
SOCIAL SCIENCE - Developing Countries.
ISBN:
9781137315854 (electronic bk.)
ISBN:
1137315857 (electronic bk.)
內容註:
1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans �Lfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans �Lfgren and Owain David Williams.
摘要、提要註:
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South.
電子資源:
http://www.palgraveconnect.com/doifinder/10.1057/9781137315854
The new political economy of pharmaceuticals[electronic resource] :production, innnovation and trips in the global south /
The new political economy of pharmaceuticals
production, innnovation and trips in the global south /[electronic resource] :edited by Hans L�ofgren, associate professor, School of Humanities and Social Sciences, Deakin University, Australia and Owain David Williams, research fellow, Centre for Health and International Relations, Aberystwyth University, UK. - 1 online resource (pages cm.) - International political economy series. - International political economy series..
1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans �Lfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans �Lfgren and Owain David Williams.
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South.
ISBN: 9781137315854 (electronic bk.)
Source: 487346Palgrave Macmillanhttp://www.palgraveconnect.comSubjects--Topical Terms:
472213
BUSINESS & ECONOMICS / Industries / General
Index Terms--Genre/Form:
336502
Electronic books.
LC Class. No.: RA401.A1 / N48 2013
Dewey Class. No.: 338.4/76151
The new political economy of pharmaceuticals[electronic resource] :production, innnovation and trips in the global south /
LDR
:04201cam 2200373Ka 4500
001
396382
003
OCoLC
005
20130913034531.0
006
m o d
007
cr cnu---unuuu
008
131202s2013 enk o 000 0 eng d
020
$a
9781137315854 (electronic bk.)
020
$a
1137315857 (electronic bk.)
035
$a
(OCoLC)855889533
035
$a
ocn855889533
037
$a
487346
$b
Palgrave Macmillan
$n
http://www.palgraveconnect.com
040
$a
UKPGM
$b
eng
$c
UKPGM
$d
OCLCO
$d
N$T
$d
IDEBK
049
$a
TEFA
050
4
$a
RA401.A1
$b
N48 2013
072
7
$a
BUS
$x
070000
$2
bisacsh
082
0 4
$a
338.4/76151
$2
23
245
0 4
$a
The new political economy of pharmaceuticals
$h
[electronic resource] :
$b
production, innnovation and trips in the global south /
$c
edited by Hans L�ofgren, associate professor, School of Humanities and Social Sciences, Deakin University, Australia and Owain David Williams, research fellow, Centre for Health and International Relations, Aberystwyth University, UK.
264
1
$a
Houndmills, Basingstoke, Hampshire :
$b
Palgrave Macmillan,
$c
2013.
300
$a
1 online resource (pages cm.)
336
$a
text
$b
txt
$2
rdacontent
337
$a
computer
$b
c
$2
rdamedia
338
$a
online resource
$b
cr
$2
rdacarrier
490
1
$a
International political economy series
505
0
$a
1. The New Political Economy of Pharmaceuticals: Conformity and Resistance in the Global South; Owain David Williams and Hans �Lfgren -- 2. The Political Economy of Pharmaceutical Production in Brazil; Cassandra M. Sweet -- 3. Pharmaceuticals, Health Policy and Intellectual Property Rights in China; Chee-Ruey Hsieh -- 4. Immunity to TRIPS? Vaccine Production and the Biotechnology Industry in Cuba; Jens Plahte and Simon Reid-Henry -- 5. TRIPS and Access to Medicines in Egypt; Dina Iskander -- 6. The Pharmaceutical Industry in India after TRIPS; Sudip Chaudhuri -- 7. The Health Care System and the Pharmaceutical Industry in Indonesia; Richard Husada and Raymond R. Tjandrawinata -- 8. TRIPS, Free Trade Agreements and the Pharmaceutical Industry in Malaysia; Mohamed Azmi Hassali, Jayabalan Thambyappa, Shankaran Nambiar and Asrul Akmal Shafie -- 9. The Pharmaceutical Industry, Intellectual Property Rights and Access to Medicines in Pakistan: Zaheer-Ud-Din Babar, Shazia Jamshed, Ashar Malik and Anwarul-Hassan Gilani -- 10. TRIPS, Access to Medicines and Local Production in South Africa; Andrew L. Gray and Yousuf A. Vawda -- 11. TRIPS and New Challenges for the Pharmaceutical Sector in South Korea; Bong-min Yang and Hye-young Kwon -- 12. Intellectual Property Rights and Neoliberal Restructuring in Turkey: The Pharmaceutical Industry; Ipek Eren Vural -- 13. Conclusion: TRIPS, Drug Production in the Global South, and Access to Medicines; Hans �Lfgren and Owain David Williams.
520
$a
Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South.
520
$a
"Some two decades will shortly have passed since the WTO's Trade Related Aspects of Intellectual Property Rights agreement came into force in 1995. TRIPS is widely considered to have had a negative impact on access to medicines through its rules on pharmaceutical patents. This volume is the first cross-country analysis of how TRIPS has affected the capacity of 11 major low or medium income countries to produce generic drugs and assesses the wider political economy of drug production and consumption in the Global South"--
$c
Provided by publisher.
588
$a
Description based on print version record.
650
7
$a
BUSINESS & ECONOMICS / Industries / General
$2
bisacsh
$3
472213
650
0
$a
Pharmaceutical policy
$x
International cooperation.
$3
551139
650
0
$a
Pharmaceutical industry
$x
Economic aspects
$x
International cooperation.
$3
551140
650
0
$a
Drugs
$x
Patents.
$3
483838
650
0
$a
Patents (International law)
$3
388690
650
7
$a
POLITICAL SCIENCE
$x
International Relations
$x
General.
$2
bisacsh
$3
473529
650
7
$a
POLITICAL SCIENCE
$x
Public Policy
$x
Social Policy.
$2
bisacsh
$3
474187
650
7
$a
POLITICAL SCIENCE
$x
Political Freedom & Security
$x
Human Rights.
$2
bisacsh
$3
473681
650
7
$a
POLITICAL SCIENCE
$x
Government
$x
International.
$2
bisacsh
$3
473678
650
7
$a
SOCIAL SCIENCE
$x
Developing Countries.
$2
bisacsh
$3
478194
655
4
$a
Electronic books.
$2
local
$3
336502
700
1
$a
L�ofgren, Hans,
$d
1953-
$3
551138
700
1
$a
Williams, Owain David,
$d
1968-
$3
523879
776
0 8
$i
Print version:
$t
New political economy of pharmaceuticals
$z
9780230284630
$w
(DLC) 2013014638
$w
(OCoLC)829739921
830
0
$a
International political economy series.
$3
375243
856
4 0
$3
Palgrave Connect
$u
http://www.palgraveconnect.com/doifinder/10.1057/9781137315854
994
$a
C0
$b
TEF
筆 0 讀者評論
多媒體
多媒體檔案
http://www.palgraveconnect.com/doifinder/10.1057/9781137315854
評論
新增評論
分享你的心得
Export
取書館別
處理中
...
變更密碼
登入